Latest News

Air China Limited recently reported its operating results for December and full-year 2025, detailing capacity, traffic, load factors, passenger volumes and cargo and mail tonnage across its network. An interesting takeaway is the closely aligned full-year passenger and overall load factors of 81.9% and 68.5%, highlighting how passenger demand compares with total capacity deployment. We will now examine how Air China’s full-year 2025 passenger load factor of 81.9% shapes the company’s broader...

If you are wondering whether Bombardier's share price still offers value after a strong run, this article walks through what the numbers actually say about the stock. At a last close of C$266.72, Bombardier has returns of 7.8% over 7 days, 16.1% over 30 days, 10.8% year to date, 197.9% over 1 year, 328.8% over 3 years and a very large gain over 5 years. Recent news coverage around Bombardier has focused largely on its capital structure, ongoing business repositioning and investor interest in...

Investors may be wondering if Phibro Animal Health is still priced reasonably after its recent run, or if the value case has already played out. The stock last closed at US$41.08, with returns of 1.5% over 7 days, 10.3% over 30 days, 10.1% year to date, 94.0% over 1 year, 193.6% over 3 years, and 119.4% over 5 years. Recent attention on the stock has focused on how its share price performance lines up with investor expectations and sector peers. This context is important because it frames...

PLS Group (ASX:PLS) is back in focus after AustralianSuper reduced its holding from 16.27% to 15.11%, as investors look ahead to the December quarter report and upcoming webcast. See our latest analysis for PLS Group. The A$4.74 share price comes after a 1 day share price return of 1.28%, a 30 day share price return of 20.61% and a 90 day share price return of 68.68%. The 1 year total shareholder return of 94.26% contrasts with a modest 3 year total shareholder return decline of 1.29%,...

BWX Technologies (NYSE:BWXT) has been highlighted by analysts and industry observers for its long-term potential in defense and nuclear markets. Recent commentary focuses on future growth tied to U.S. naval nuclear propulsion programs supported by the 30-year U.S. Navy shipbuilding plan. Additional attention centers on BWXT's exposure to the AUKUS partnership, commercial nuclear opportunities, and medical isotope production. BWX Technologies sits at the intersection of defense and nuclear...

Wesdome Gold Mines (TSX:WDO) is back on investors' radars after confirming record 2025 gold production, strong free cash flow, and setting 2026 guidance of 180,000 to 205,000 ounces, alongside a record $55 million exploration budget. See our latest analysis for Wesdome Gold Mines. Those production records, a larger 2026 exploration program and a COO transition have arrived alongside a 30 day share price return of 14.24% and a 1 year total shareholder return of 104.63%, suggesting momentum has...

In early January 2026, several major brokers including Piper Sandler, Morgan Stanley, and KeyBanc upgraded or reaffirmed positive ratings on Arista Networks, citing its growing role in AI infrastructure and hyperscaler data center buildouts ahead of its February 12 earnings release for the quarter ended December 31, 2025. This cluster of bullish views highlights how investors increasingly see Arista as a focused beneficiary of AI-driven networking demand, even as competition from whitebox...

Level2 partnership puts automation at the center of Webull’s pitch Webull (BULL) has drawn fresh attention after announcing a partnership with Level2 that embeds visual, no code automated trading tools directly into its platform for US retail users. The move gives Webull clients access to drag and drop strategy building, real time backtesting, and community shared strategies without separate software or custom coding. This consolidates research and execution in one place. See our latest...

Cogent Biosciences (COGT) stock is in focus after the FDA agreed to accept its New Drug Application for bezuclastinib plus sunitinib in previously treated GIST patients under the Real Time Oncology Review program. See our latest analysis for Cogent Biosciences. That FDA news drops into a backdrop where the share price has a 90 day share price return of 168.69% and a very large 1 year total shareholder return, so recent momentum looks strong rather than fading. If this kind of biotech move has...

If you are looking at Kering and wondering whether the current share price reflects its true worth, this article is written with that exact question in mind. The stock recently closed at €269.65, with returns of 11.2% over 1 year but declines of 12.8% over 7 days, 10.9% over 30 days, 11.5% year to date, and 45.1% and 43.7% across 3 and 5 years respectively. This can signal changing views on both risk and opportunity. These moves have come alongside ongoing headlines around the wider luxury...

Why Fortinet is on investors’ radar today Fortinet (FTNT) is back in focus after a stretch of weaker share performance, with the stock showing negative returns over the past month, past 3 months, and year, even as longer term returns remain positive. That gap between recent weakness and multi year gains is prompting investors to reassess what they are paying for a business that reports US$6,554.7m in revenue and US$1,873.6m in net income, alongside a current value score of 5. See our latest...

Recent commentary around Cadeler (OB:CADLR) centers on its focus on next generation, high capacity offshore wind turbines and a rapidly expanding installation fleet. This combination could reshape how investors think about this specialist contractor. See our latest analysis for Cadeler. The recent focus on next generation offshore wind projects appears to be lining up with improving momentum in Cadeler’s shares, with a 30 day share price return of 14.50% and an 11.12% year to date share price...

Recent share performance and what it might signal PTC (PTC) has recently traded under pressure, with the share price showing a 3.4% decline over the past day, 4.9% over the past week, and about 9.6% over the past month. Over the past 3 months, the stock is down roughly 20.6%, while the year-to-date move is a 5.3% decline and the past 1-year total return is a 14.3% decline, setting a cautious backdrop for investors. See our latest analysis for PTC. With the latest share price at $161.11, PTC’s...

Recent share performance and business snapshot Wix.com (WIX) has recently seen weaker share performance, with returns over the past month, past 3 months and year all in negative territory. This naturally draws attention to its underlying business metrics. The company reports annual revenue of US$1.93b and net income of US$138.9m, with annual revenue growth of 11.0% and net income growth of 24.7%. These figures give investors concrete data to weigh against the recent share price pullback. See...

Recent performance snapshot Teck Resources (TSX:TECK.B) has drawn fresh attention after a solid recent run, with the stock showing positive returns over the past month, past 3 months, year to date, and over the past year. For context, Teck Resources reports annual revenue of CA$10.484b and net income of CA$1.242b. Both revenue and net income growth figures are provided on an annual basis, which helps frame its current valuation and performance profile. See our latest analysis for Teck...

General Dynamics recently secured a US$988 million U.S. Navy contract to modernize C5ISR networks across ships, aircraft, and land-based stations, reinforcing its role as a key defense technology provider. This award, combined with ongoing contract wins in both defense and Gulfstream business jets, highlights the breadth and resilience of General Dynamics’ diversified revenue base. Next, we’ll examine how this major C5ISR modernization contract shapes General Dynamics’ investment narrative...

Similarweb (SMWB) is back on investor radars after announcing a collaboration with autonomous AI platform Manus, giving Manus agents direct access to Similarweb’s web traffic and engagement data for marketing analysis. See our latest analysis for Similarweb. The Manus partnership comes at a weaker moment for the stock, with a 1 day share price return of a 4.1% decline and a 30 day share price return of a 15.6% decline. The 1 year total shareholder return of a 62.2% decline points to pressure...

Karooooo Ltd. reported its third-quarter and nine-month results to November 30, 2025, showing higher sales of ZAR 1,409.83 million and ZAR 4,030.74 million respectively, alongside increased net income and earnings per share compared with the same periods a year earlier. An interesting takeaway is that both basic and diluted earnings per share from continuing operations moved in lockstep, rising to ZAR 8.55 for the quarter and ZAR 24.98 for the nine months, suggesting limited dilution from...

Cisco Systems (NasdaqGS:CSCO) has agreed a multi year partnership with Georgetown University to deploy one of the largest Wi Fi 7 rollouts in higher education. The project aims to modernize campus connectivity and support data heavy applications for students, faculty, and research programs. Separately, Cisco has entered into an AI infrastructure partnership with Sharon AI focused on customers in Australia and the wider Asia Pacific region. The Sharon AI collaboration is designed to support...

Earlier in January 2026, Biohaven reported encouraging early clinical experience from its proprietary MoDE™ and TRAP™ extracellular protein degrader platforms, showing rapid removal of disease-causing proteins and associated clinical improvements in IgA nephropathy and Graves’ disease, alongside continued progress in its broader neurology and rare disease pipeline. The company also used its presentation at the 44th Annual J.P. Morgan Healthcare Conference to spotlight these first-in-class...

What sparked the latest move in Nova (NasdaqGS:NVMI)? The recent move in Nova (NasdaqGS:NVMI) was largely tied to Taiwan Semiconductor Manufacturing Co.'s stronger than expected quarterly results. These results reinforced market confidence in demand for AI focused chips and equipment suppliers. See our latest analysis for Nova. Beyond the TSMC driven move, Nova’s recent momentum has been strong, with a 30 day share price return of 40.04% and a 1 year total shareholder return of 74.90%, while...

Without a specific news catalyst in play, Medline (MDLN) is drawing investor attention after recent share price moves and solid reported fundamentals, including annual revenue of US$27.4b and net income of US$1.3b. See our latest analysis for Medline. With the share price at US$44.15, Medline’s recent 7 day share price return of 3.03% and 30 day share price return of 6.00% suggest momentum has been building in the year to date, where the share price return stands at 8.69%. If Medline’s move...

In January 2026, Singapore Airlines reported its December 2025 group operating results, showing higher passenger capacity, revenue passenger kilometers, and passengers carried, alongside increased cargo capacity, load, and volumes compared with a year earlier. While passenger load factor edged slightly lower, the combination of rising passenger volumes and improved cargo load factor highlighted broad-based operational strength across the network. Next, we will examine how December’s higher...

Why BNP Paribas (ENXTPA:BNP) is on investors’ radar today BNP Paribas (ENXTPA:BNP) shares have attracted attention recently as investors consider the bank’s current valuation, recent share performance and financial profile, including revenue of €46,870m and net income of €10,846m. See our latest analysis for BNP Paribas. At a share price of €86.42, BNP Paribas has cooled slightly over the past week but still carries a 30 day share price return of 7.22% and a 90 day gain of 26.40%. The 1 year...